STOCK TITAN

Nano-X Imaging (NNOX) CFO returns 39,474 ordinary shares to issuer

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Nano-X Imaging Ltd. CFO Daniel Ran reported a disposition of ordinary shares back to the company. On March 18, 2026, he transferred 39,474 ordinary shares to the issuer at a stated price of $0.00 per share. After this issuer-related disposition, he directly holds 46,424 ordinary shares, according to the filing.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Daniel Ran

(Last)(First)(Middle)
104-20 QUEENS BLVD.
15J

(Street)
FOREST HILLS NEW YORK 11375

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Nano-X Imaging Ltd. [ NNOX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
CFO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/18/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary shares03/18/2026D39,474A$046,424D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
Remarks:
The ordinary shares reported in this row consist of shares underlying restricted share units that were granted to the Reporting Person on March 18, 2026 and of which 50% will vest on the 12-month anniversary of the grant date and the remaining 50% will vest upon the 24-month anniversary of the grant date.
Ran Daniel03/25/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Nano-X Imaging (NNOX) report for CFO Daniel Ran?

Nano-X Imaging reported that CFO Daniel Ran disposed of 39,474 ordinary shares back to the issuer. The transaction involved non-derivative ordinary shares and is classified as a disposition to the issuer rather than an open-market trade.

When did the Nano-X Imaging (NNOX) CFO share disposition occur?

The disposition of Nano-X Imaging ordinary shares by CFO Daniel Ran occurred on March 18, 2026. The filing records this date as the official transaction date for the issuer-related share disposition of 39,474 ordinary shares.

How many Nano-X Imaging (NNOX) shares does the CFO hold after this Form 4?

Following the issuer disposition, CFO Daniel Ran directly holds 46,424 ordinary shares of Nano-X Imaging. This post-transaction balance reflects his remaining direct non-derivative holdings as reported in the Form 4 filing data.

Was the Nano-X Imaging (NNOX) CFO transaction an open-market sale?

No. The transaction is classified as a disposition to the issuer with a reported price of $0.00 per share. This indicates the shares were returned to Nano-X Imaging rather than sold through an open-market transaction.

What type of security was involved in the Nano-X Imaging (NNOX) CFO transaction?

The transaction involved ordinary shares of Nano-X Imaging, reported as a non-derivative security. CFO Daniel Ran disposed of 39,474 ordinary shares to the issuer and directly holds 46,424 ordinary shares after the transaction.
Nano-X Imaging Ltd.

NASDAQ:NNOX

View NNOX Stock Overview

NNOX Rankings

NNOX Latest News

NNOX Latest SEC Filings

NNOX Stock Data

167.02M
69.06M
Medical Devices
Healthcare
Link
Israel
Petah Tikva